Tag: diabetes treatment in Brazil

Biocon and Biomm ink exclusive deal to bring Semaglutide to Brazil

Biocon Limited (BSE code: 532523, NSE: BIOCON), a leader in global biopharmaceutical innovations, has announced a pivotal licensing and supply agreement with Brazil's Biomm S.A., ... Read More